GLAX Health Press Releases

• Published on July 1, 2022 - 08:03 GMT

  

  New Drug for New Target – Dr. Rakesh Srivastava

  New Drug for New Target – Dr. Rakesh Srivastava WILMINGTON, DELAWARE, UNITED STATES, July 1, 2022 /⁨EINPresswire.com⁩/ -- GLAX LLC, a biotechnology company, is developing targeted therapies for cancer, diabetes, and neurodegenerative disorders. The main …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on June 23, 2022 - 17:08 GMT

  

  GLAX LLC Announces Issuance of U.S. Patent for Tumor Targeted Therapy for Cancer - Dr. Rakesh K. Srivastava

  WILMINGTON, DE, USA, June 23, 2022 /⁨EINPresswire.com⁩/ -- GLAX LLC Announces Issuance of U.S. Patent for Tumor Targeted Therapy for Cancer - Dr. Rakesh K. Srivastava GLAX LLC, a biotechnology company developing targeted therapies for cancer and …

  Distribution channels: Business & Economy, Conferences & Trade Fairs ...
• Published on June 22, 2022 - 19:38 GMT

  

  GLAX LLC Obtained Patents to Treat Human Diseases – Dr. Rakesh K. Srivastava

  GLAX LLC Obtained Patents to Treat Human Diseases – Dr. Rakesh K. Srivastava NEW ORLEANS, LA, USA, June 22, 2022 /⁨EINPresswire.com⁩/ -- GLAX LLC Obtained Patents to Treat Human Diseases – Dr. Rakesh K. Srivastava GLAX LLC is dedicated in developing …

  Distribution channels: Banking, Finance & Investment Industry, Education ...
• Published on May 26, 2022 - 21:50 GMT

  

  Dr. Rakesh Srivastava – Discovery of A New Drug for The Treatment of Alzheimer’s Disease and Cancer (Dual Targets)

  Discovery of A New Drug for The Treatment of Alzheimer’s Disease and Cancer - Dr. Rakesh Srivastava WILMINGTON, DE, UNITED STATES, May 26, 2022 /⁨EINPresswire.com⁩/ -- Dr. Rakesh K. Srivastava (President and CEO of GLAX Health) and his international …

  Distribution channels: Business & Economy, Chemical Industry ...
• Published on December 16, 2021 - 16:57 GMT

  

  Dr. Rakesh Srivastava - Discovery of A New Anti-Inflammatory Drug for Human Diseases

  Dr. Rakesh Srivastava - Discovery of A New Anti-Inflammatory Drug for Human Diseases WILMINGTON, DE, USA, December 16, 2021 /⁨EINPresswire.com⁩/ -- Dr. Rakesh K. Srivastava (President and CEO of GLAX Health) and his international collaborator (a team from …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...